Indrayani Biotech Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 49,896 shares,. Its Average Traded Price (ATP) is ₹10.79, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 59 @ ₹10.80.
Indrayani Biotech has an upper circuit limit of ₹13.09 and a lower circuit limit of ₹8.73. The total value traded stands at ₹5.38 L, and the delivery percentage for the day is 75.2%.
The stock is currently traded with a market lot size of 1. Indrayani Biotech also offers a dividend yield of 0%.
Indrayani Biotech Share Price Chart
Indrayani Biotech Share Key Metrics
Volume
49896.00
Market Cap
49.32 CR
LTQ@LTP
59@10.80
ATP
10.79
Var Margin
28.94 %
Circuit Range
8.73-13.09
Delivery %
75.2 %
Value
5.38 L
ASM/GSM
No
Market Lot
1
Indrayani Biotech Resistance and Support
Pivot 10.73
Resistance
First Resistance
11.46
Second Resistance
12.02
Third Resistance
12.75
Support
First Support
10.17
Second Support
9.44
Third Support
8.88
Indrayani Biotech Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Indrayani Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-17 | Audited Results |
| 2026-04-09 | Scheme of Arrangement |
| 2026-02-26 | Quarterly Results |
| 2025-12-11 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-30 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-06-12 | Audited Results |
| 2025-06-09 | Audited Results |
| 2025-04-03 | Rights issue of Equity Shares |
| 2025-02-27 | Quarterly Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Rights issue |
| 2024-08-14 | Quarterly Results |
| 2024-07-27 | Others |
| Rights Date | Ratio | |
|---|---|---|
| 2026-04-28 | 5:7 | View More |
Indrayani Biotech News
Indrayani Biotech Ltd - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Indrayani Biotech published a pre-issue advertisement for its Rights Issue. The issue will open on September 15, 2026, and close on October 14, 2026.
Sep 15 2026 11:56:05
Indrayani Biotech Ltd - 526445 - Letter Of Offer For Rights Issue
Indrayani Biotech plans a rights issue of up to Rs. 48.79 crores at Rs. 15 per share (ratio 5:7) to fund working capital and repay promoter/BIPL loans. The company's auditors, however, have raised multiple qualifications regarding interest-free loans to subsidiaries, statutory dues defaults, lack of audit trail in accounting software, and unconfirmed trade creditors. Past regulatory non-compliance and fines also noted.
Sep 09 2026 20:29:34
Indrayani Biotech Ltd - 526445 - Corporate Action-Outcome of Right issue
Indrayani Biotech's Rights Issue schedule has been revised by the Rights Issue Committee. The issue will now be open from September 15, 2026, to October 14, 2026, with renunciation by October 08, 2026.
Sep 09 2026 20:22:36
Indrayani Biotech Ltd - 526445 - Extension Of Time Granted For Holding The AGM For FY 2025-26
Indrayani Biotech has been granted a 2-month extension by ROC Chennai to hold its 34th Annual General Meeting for FY 2025-26, shifting the deadline to November 30, 2026. The delay is attributed to ongoing capital restructuring efforts, which include a proposed Rights Issue requiring multiple approvals.
Sep 07 2026 17:46:09
Indrayani Biotech Ltd - 526445 - Result-Audited Financial Results For Quarter And Year Ended March 31, 2026 Along With Report Of Statutory Auditor.
Indrayani Biotech's auditor issued a qualified opinion on the annual consolidated and standalone financial results for FY26. Key concerns include unconfirmed balances for loans, trade receivables, and 41% of trade creditors, and non-IND AS consolidation for certain subsidiaries.
Aug 19 2026 16:18:25
Indrayani Biotech Ltd - 526445 - Board Meeting Outcome for Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31St March 2026 Along With Report Of Statutory Auditors.
Indrayani Biotech's board approved audited financial results for FY26, with a consolidated profit of ₹216.03 lakhs and standalone profit of ₹69.97 lakhs. Auditors issued a qualified opinion citing unconfirmed balances and non-compliant accounting for subsidiaries.
Aug 17 2026 16:56:55
Indrayani Biotech Management
| Name | Position |
|---|---|
| NM Ranganathan | Chairman |
| Kasiraman Sayee Sundar | Managing Director |
Indrayani Biotech Similar Stocks
Gillanders Arbuthnot & Company Ltd.
101.45
-0.05 (0.05%)
TCI Industries Ltd.
1255.00
45.00 (3.72%)
Krypton Industries Ltd.
34.99
0.15 (0.43%)
Finelistings Technologies Ltd.
13.30
-0.70 (5.00%)
BIL Vyapar Ltd.
4.16
0.16 (4.00%)
Vishvprabha Ventures Ltd.
40.20
0.00 (0.00%)
BNR Udyog Ltd.
36.50
-1.42 (3.74%)
Skyline Ventures India Ltd.
21.00
0.00 (0.00%)
Indrayani Biotech FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in INDRANIB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC